Anti-tumor properties of silver

Area of Science:

• Biochemistry
• Nanotechnology
• Oncology

Background:

• Silver has historical uses and recent interest in its electronic and chemical properties.
• Cisplatin, a platinum-based chemotherapy drug, has been widely used since the 1970s for various cancers.
• The potential of metal-based compounds as alternatives in new technologies and therapies is being explored.

Purpose of the Study:

• To investigate the biological effects of silver compounds on cancer cell lines.
• To determine an optimal, non-cytotoxic concentration of silver for potential therapeutic applications.
• To evaluate the impact of silver treatment on the gene expression profile of cancer cells.

Main Methods:

• Culturing of laryngeal carcinoma (HEP2) and tongue carcinoma (PE15, PE46) cell lines.
• Treatment of cell lines with increasing concentrations of silver (Ag) to assess viability.
• Gene expression profiling of 10 cell cycle-related genes following silver treatment.

Main Results:

• An optimal silver concentration of 0.007% was identified, showing no significant impact on cell viability.
• Gene expression analysis in the HEP2 cell line revealed minimal changes.
• Only the CCNE1 gene was significantly down-regulated (≤ 0.5-fold change); other genes showed comparable expression to controls.

Conclusions:

• Silver compounds, at the tested concentration, do not significantly affect cancer cell viability or the expression of most studied cell cycle genes.
• Further research into the biological mechanisms of silver compounds is crucial for developing novel, low-toxicity anti-cancer drugs.
• Silver-based therapies may offer a promising alternative for treating human and animal neoplasia.